Any potential conflict will be identified and managed according to ACCME guidelines and ASTROs COI management policies. } Get details about special events and happenings for the patient community at and in conjunction with the ASCO Annual Meeting. .post_image{

9 Presentations must be objective and free of commercial bias for or against any product or device. Top Trade Shows | Trade Show List | Trade Show and Conference Calendar | Top Technology Trade Shows List | Top Technology Conference List | Top Healthcare Trade Shows List | Top Healthcare Conference List | Top Medical Devices Trade Shows List | Top Medical Devices Conference List | Top Consumer Electronics Trade Shows List | Top Consumer Electronics Conference List | Top Supply Chain Trade Shows List | Top Supply Chain Conference List | Top Military and Defense Trade Shows List | Top Military and Defense Conference List | Top Agriculture Trade Shows and Fairs List | Top Agriculture Conference List | Top Energy Trade Shows List | Top Energy Conference List | Top Health & Fitness Trade Shows List | Top Health & Fitness Conference List | Top Food & Hospitality Trade Shows List | Top Food & Hospitality Conference List | Top Government Trade Shows List | Top Government Conference List | Top Home Shows List | Top Home & Interior Design Conference List | Top Boat Shows List | Top Flower Shows List | Top Orchid Shows List | Top Women Shows List | Top Fashion & Beauty Trade Shows List | Top Apparel Trade Shows List | Top Retailer Trade Shows List | Top Medical & Pharma Trade Shows List | Top Medical & Pharma Conference List | Top Auto Shows List | Top Franchise Trade Shows List | Top Book Shows Expos List | Top Publisher Industry Conference List | Professional Speakers | Top Speakers Bureau List | Trade Show Supplier Directory | Trade Show Exhibitor Tools | Largest Trade Show Exhibitor List by Industries | Largest Conference Sponsor List by Industry | Top Medical & Pharma Exhibitor List | Top Virtual Events List | Top Virtual Conference List | Top Online Trade Shows List | Top Supply Chain Virtual Events List | Best Practices for Trade Shows | Best Practices for Trade Show Exhibitors | How to Build Virtual Booths | Top Travel & Tourism Trade Shows List | Top Travel & Tourism Conference List | Top Manufacturing Trade Shows List | Top Manufacturing Conference List | Top Audio Visual Services Providers List | Top Venues for Trade Shows | Top Conference Centers List | Top Convention Centers List | Las Veas Trade Shows List | Top Trade Shows Las Vegas List | Top Trade Shows Orlando List | Top Trade Shows Houston List | Top Trade Shows Boston List | Top Trade Shows San Diego List | Top Trade Shows Honolulu List | Top Trade Shows Miami List | Miami Beach Convention Center Event Calendar | Las Vegas Convention Center Event Calendar | Orlando Convention Center Event Calendar | Event Planner Tools | Association Event Management Registration Tools | Association Event Management Software | Online Event Management System | Online Event Registration | Suppliers and exhibitors, McCormick Place Convention Center, Chicago, Illinois, 2023 ASCO Annual Meeting - American Society Of Clinical Oncology, 2022 ASCO Annual Meeting - American Society Of Clinical Oncology, 2021 ASCO Annual Meeting - American Society Of Clinical Oncology, 2020 ASCO Annual Meeting - American Society Of Clinical Oncology, American Society of Clinical Oncology 2019 Annual Conference & Expo, American Society of Clinical Oncology 2018 Annual Conference & Expo, 2017 ASCO Annual Meeting - American Society Of Clinical Oncology, 2016 ASCO Annual Meeting - American Society Of Clinical Oncology, 2015 ASCO Annual Meeting - American Society Of Clinical Oncology, 2014 ASCO Annual Meeting - American Society Of Clinical Oncology, 2013 ASCO Annual Meeting - American Society Of Clinical Oncology, Precision Prevention, Early Detection, and Interception of Cancer, 2022 Association of Cancer Executives Meeting (ACE Meeting), Advanced Therapies Week 2022 (Formerly known as Phacilitate Leaders World), Global Oncology Site Solutions Summit 2022. .p-theme span{ 2318 Mill Road, Suite 800 Alexandria, VA 22314 571-483-1300. Authors of abstracts accepted as digital posters will be required to upload their poster in advance of the meeting. Is there an appropriate use of statistics? To sign up for ESMO newsletters,create a myESMO account hereand select the newsletters youd like to receive. The organization continues to work to harness rapid changes in science and technology to achieve even better outcomes for tomorrows patients. /* ----------------------------------------- */ }

10 +. Alternative language includes at one institution, a multi-institution study, etc. This website uses cookies to deliver to you the best experience possible on SITC CONNECT. More information about the award and the award application will be available on the actual abstract submission site. Embargo violations by media professionals may result in suspension of credentials at the 2021 Multidisciplinary Thoracic Cancers Symposium as well as future meetings and may also impact the ability to receive advance media materials for future meetings. Copyright 2022 PR Medical Events. Abstracts must be properly formatted and organized into four sections, identified by the following bolded headers: Purpose/Objectives, Materials/Methods, Results, and Conclusion. /* ----------------------------------------- */ | VAT: RO31767934 Planning committees have the right to re-categorize any abstract as deemed appropriate. The financial relationships of spouse/partners are considered relevant financial relationships of the presenter. This website uses cookies to ensure the best user experience. Sixth CRI-ENCI-AACR Cancer Immunotherapy Conference, EORTC-ESMO-AACR Methods in Clinical Cancer Research, AACR/ASCO Methods in Clinical Cancer Research, Translational Cancer Research for Basic Scientists, Accelerating Anticancer Agent Development, Accelerating Anticancer Agent Development and Validation, Eliminating Racial Inequities In Cancer Research, Scientific Achievement Awards and Lectureships, Science Policy and Government Affairs Committee. As such, inclusion of results would be improper and is strictly forbidden. 2 Was there a rationale, either clinical or laboratory, underlying the study design? A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Presentations must give a balanced view of therapeutic options. This applies only to abstracts presented in sessions selected to receive CME (oral presentations). All meeting abstracts are embargoed until Thursday, December 2, at 8:00 a.m. Mountain time. Are the conclusions appropriate to the study design? Please fill in all of the details and let us know the specifics of your request in the details text field. COPYRIGHT 2002 - 2022 DIGITAL SCIENCE PRESS, LLC. Is the cohort well described and reasonably homogeneous? Create Profile. Email: [emailprotected], Cancer Researchers / Other Health Care Professionals, Eliminating Racial Inequities in Cancer Research, JCA-AACR Latest Advances in Pancreatic Cancer Research. Two awards will be granted to recognize outstanding abstracts submitted by early career authors. AACR Special Conference: Rethinking DCIS: An Opportunity for Prevention? Take the time to familiarize yourself with the different opportunities the Annual Meeting offers. A sales representative will get in touch with you very soon. in the scientific content in the abstract. The planning committees will exercise all rights in ensuring that abstracts reporting the discovery of scientific research remain in compliance with ACCME standards for ensuring independence in CME activities. Trials in Progress provide an opportunity for members of the research community to present ongoing trials, foster collaboration, and discuss correlatives and novel trial designs. 2022 Society for Immunotherapy of Cancer (SITC). Since 2008 EventsInAmerica.com All Rights Reserved. Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: info@sitcancer.org. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences. Europes Beating Cancer Plan in 60 minutes, World Cancer Report Updates Learning Platform, ESMO Scale for Clinical Actionability of molecular Targets (ESCAT), Recognition and Status of Medical Oncology, Status of Medical Oncology in Developing Countries, Shortages of Inexpensive, Essential Cancer Medicines, Accessibility and Availability of Medicines, Availability and Accessibility of Biomolecular Technologies in Oncology, CAREFOR, The Clinical Academic Cancer Research Forum, World Health Organization / United Nations, ESMO responses to European Union and Global Public Consultations, ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer, ESMO Preceptorship on Head & Neck Cancer 2022: Singapore, ESMO Preceptorship on Ovarian Cancer 2022: Lisbon, ESMO Preceptorship on Breast Cancer 2022: Lugano, ESMO Preceptorship on Adolescent and Young Adult Malignancies 2022: Athens, Annual Meeting of the German, Austrian and Swiss Associations for Haematology and Medical Oncology, ESMO Advanced Course on Biomarkers for Precision Medicine 2022: Singapore, Molecular Analysis for Precision Oncology Congress 2022, 60th Annual Meeting of the Japan Society of Clinical Oncology (JSCO), ESMO Preceptorship on Prostate Cancer 2022: Lugano, ESMO Advanced Course on Early Stage NSCLC 2022: Melbourne, 23rd European Congress on Gynaecological Oncology (ESGO) - Joint Session ESMO-ESGO-ESP Consensus Conference on Ovarian Cancer 2022, ESMO Preceptorship on Gastric Cancer 2022: Valencia, 14th European Multidisciplinary Congress on Urological Cancers, ESMO Preceptorship on Lung Cancer and Other Thoracic Malignancies 2022: Paris, ESMO Advanced Course on Biomarkers for Precision Cancer Medicine 2022: Zurich, ESMO Virtual Advanced Course on KRAS Targeting in NSCLC 2022, ESMO Preceptorship on Breast Cancer 2022: Singapore, ESMO Preceptorship on Gastric Cancer 2022: Singapore, ESMO Preceptorship on Immuno-Oncology 2022: Singapore, ESMO Virtual Advanced Course on NTRK 2022, ESMO Preceptorship on Immuno-Oncology 2022: Zurich, ESMO Preceptorship on NSCLC 2023: Singapore, ESMO Preceptorship on Breast Cancer: South Africa. Abstracts must be received by 11:59 p.m. Pacific time on Wednesday, September 15. Mesothelioma, Thymic Malignancies, Carcinoid Tumors and Other Thoracic Malignancies, Non-small Cell Lung Cancer: Locally Advanced, Non-small Cell Lung Cancer: Oligometastatic. What were the eligibility criteria and study patient characteristics? Are the findings either promising enough to pursue or negative enough that presentation would prevent other investigators from wasting efforts? It is acceptable if the trial has not enrolled its first patient yet. Brand names of pharmaceuticals and trade names of medical devices should not be used in the title or body of the abstract. Questions about the embargo policy may be directed to the ASTRO media relations team. Have attempts been made to account for biases inherent in retrospective reviews? Your presence at this global event will allow you to: Trials in Progress will be considered for digital poster only. Educated and informed patients with cancer. /* ----------------------------------------- */ table{ Receive information and updates on ESMOs scientific and educational resources, events, members activities. The presenting author will receive all notifications and communications related to the accepted abstract(s) and is responsible for informing all co-authors of acceptance and COI policies. Submission of an abstract conveys permission for the full text to be published in the. Designed for trade association, exhibitors, academic institutions and speakers, List and promote your online events. For abstracts that are accepted, presenters may include these items in their on-site presentations. padding-left: 4px; Generate new sales leads If trade names are used, those of several companies should be used rather than only that of a single supporting company. All oral abstract presenters must abide by the following expectations: You are required to disclose before your talk. Learn more here. 555 East Wells Street, Suite 1100 | Milwaukee, WI | 53202-3823 | USA. All rights reserved worldwide, How to Follow ASCOs Annual Meeting on our Social Media, ASCO Care and Treatment Recommendations for Patients. ESMO Facebook Roundtable: COVID-19 Vaccines and Cancer Care - The known, the unknown and the unknowable, ESMO Facebook Roundtable: COVID-19 vs Cancer - Reorganising cancer care after the first wave, ESMO Facebook Roundtable: COVID-19 vs Cancer - The future of cancer research, ESMO Facebook Roundtable: COVID-19 vs Cancer - Weighing up risks over time, Cancer Patient Management During the COVID-19 Pandemic, COVID-19 and cancer care in the ESMO journals, Adolescents and Young Adults Working Group, ESMO SIOG Cancer in the Elderly Working Group, Examination & Accreditation Working Group, Translational Research and Precision Medicine Working Group, Real World Data and Digital Health Working Group, ESMO-Magnitude of Clinical Benefit Scale Working Group, Press and Media Affairs Committee and Social Media Working Group, ESMO Clinical Research Observatory Task Force (ECRO), From strength to strength for better patient care, Scientific excellence driving optimal cancer care: counting down to our Congress, ESMO 2018 Congress: myriad must-attends in Munich, Reflections and next step directions from your new President, Maintaining the pace of research: A word from your President, Equal opportunities, care, continuity: Perspectives from your new President, Ensuring the long-term sustainability of what we do, Primary brain tumours in the COVID-19 era, Gastrointestinal cancers: Hepatocellular carcinoma (HCC) in the COVID-19 era, Genitourinary cancers: Urothelial cancer of the bladder in the COVID-19 era, Genitourinary cancers: Renal cell cancer in the COVID-19 era, Genitourinary cancers: Prostate cancer in the COVID-19 era, Gynaecological malignancies: Cervical cancer in the COVID-19 era, Gynaecological malignancies: Endometrial cancer in the COVID-19 era, Haematological malignancies: DLBCL, MCL and Aggressive T-cell lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA), Haematological malignancies: Hodgkin lymphoma in the second phase of the COVID-19 pandemic (ESMO-EHA), Haematological malignancies: Indolent B-NHL in the second phase of the COVID-19 pandemic (ESMO-EHA), Haematological malignancies: Multiple myeloma in the COVID-19 era, Head and neck cancers in the COVID-19 era, COVID-19 adapted recommendations Slide Sets, ESMO-ESO Courses on Medical Oncology for Medical Students, Protecting Cancer Patients Against COVID-19, ESMO Guidelines: Real World Cases - Webinar Series, Applications of Liquid Biopsy - ESMO Webinar Series, SARS-CoV-2 Vaccination: Special Considerations in Patients with Cancer.

ASCO Promotes and Provides For A PR Medical Events representative will call you back as soon as possible. Sponsorship or membership with one of the co-sponsoring organizations is not required to submit an abstract. Testing and Targeting Tumours with RET Alterations, Past ESMO Partnership, Labelled and Supported Meetings, Acknowledgements: Rationalizing Bureaucracy, Bibliography on Clinical Trial Procedures, ESMO Designated Centres of Integrated Oncology & Palliative Care, Palliative and Supportive Care Sessions at ESMO Asia Virtual Congress 2020, ESMO Public Policy Track and Special Sessions. Youll meet friends and make connections, and bring back new ideas to your practices and hospitals. This does not apply to cooperative research group names. All abstracts to be presented at the 2021 Multidisciplinary Thoracic Cancers Symposium are embargoed untilThursday, December 2 at 8:00 a.m. Mountain time. Such presentations will be subject to a rigorous peer review process to ensure the validity of the research review process, results and conclusions. It looks like you're using Internet Explorer 11 or older. 700065, Romania, Email: operations@pr-medicalevents.com If the presenting author is employed by a commercial interest, as defined above, an alternate presenter must be named. An individual may submit more than one abstract in which he or she is indicated as the first author, but he or she may only present one oral presentation. Cancer.Net's information helps put these results into context, through the following sections: Guides to highlighted research summarized for patients from the ASCO Annual Meeting. Presentations must give a balanced view of therapeutic options. Build your brand, generate quality leads, and close more sales! Spaces are not counted. Tourism License Number: 1591 / 25.03.2019 A commercial interest is defined as any entity developing, producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients.) Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. z-index: 0 This site uses cookies. The Annual Meeting brings together 32,000+ oncology professionals from around the world. If more than one abstract is selected for oral presentation, an alternate presenter must be assigned, preferably a co-author (this does not apply to poster presentations). 8 The person submitting the abstract is not required to be an author on the abstract and will be able to select the first/presenting author on the designated step. Complimentary registration to the symposium is included in the award. All submitters agree to cooperate in the publicity of their study. Your ASCO username and password are required to log in and edit the submission. Authors, Presenters, and Conflict of Interest (COI) Policies, 2021 Multidisciplinary Thoracic Cancers Symposium abstracts. In this section, Cancer.Net offers news for patients, and their family and friends, about the many cancer care and treatment advances announced during the American Society of Clinical Oncology's (ASCO) Annual Meeting each year. Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience. padding-bottom: 30px; The title of the abstract should not contain results. Lifelong learning for oncology professionals, 2005-2022 American Society of Clinical Oncology (ASCO). All phases of clinical research (phases I to III, supportive care, nonpharmacologic interventions) may be considered for inclusion as a Trials in Progress submission. margin: 0 auto; Are the endpoints of the study clearly defined? Educational sessions feature world-renowned faculty discussing state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. 4 Chantry Court, Chester A global network of oncology expertise, and To submit an abstract, you will need to log in with an ASCO.org account. Monitor. CH1 4QN, United Kingdom, Email: office@pr-medicalevents.com (Employment of spouse/partner is not considered employment by the presenter; however, it will be considered a relevant financial relationship.). Clinical Practice Guidelines Online Education, Richard V. Smalley Memorial Award and Lectureship, Corporate Support and Giving Opportunities, Committees, Task Forces and Professional Interest Communities. A list of submission categories is listed below and in the online submission site. Enrollment must have already begun or have been completed with no data analysis available by the submission deadline (there are no exceptions to this criterion).

Attendees will be able to access digital posters in an online virtual library both on-site and after the conclusion of the symposium. ESMO is a Swiss-registered not-for-profit organisation. .details-tabs{ Cancer Researchers / Other Health Care Professionals, myAACR Support: Virtual Meeting Access / Registration, Scholar-in-Training Awards: Annual Meeting, AACR Minority Scholar in Cancer Research Awards, AACR Minority and Minority-serving Institution Faculty Scholar in Cancer Research Awards, AACR Scholar-in-Training Awards: Other Conferences and Meetings. Cancer research, Please enable scripts and reload this page. Presentations must be HIPAA compliant (e.g., will only use de-identified patient information and/or will obtain written consent from the patient). Thousands of scientific abstracts are released at the ASCO Annual Meeting, and the news announced includes the latest findings from cancer clinical trials, including new drug studies, that could change patient care. .congress-details{ Comprehensive information for people with cancer, families, and caregivers, from the American Society of Clinical Oncology (ASCO), the voice of the world's oncology professionals. } The 2022 ASCO Annual Meeting was held June 3-7, 2022. Presenters are required to disclose the following, if applicable, to the audience at the beginning of your presentation and in accordance with ACCME standards and Food and Drug Administration requirements: The existence of any financial or other relationship you have with the manufacturer(s) or any commercial product(s) or provider(s) of any commercial services discussed in an educational presentation. Careers | Embargo violations by abstract authors and/or sponsors may result in removal of the abstract from the scientific program. To ensure its compliance, ASTRO expects that the content and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias. AAPM(American Association of Physicists in Medicine), EUSOBI(European Society of Breast Imaging), MICCAI (Medical Image Computing and Computer Assisted Intervention Society), WMIC(World Molecular Imaging Conference), RSNA(Radiological Society of North America), AACR(American Association for Cancer Research), ISMRM(International Society for Magnetic Resonance in Medicine), ASCO(American Society of Clinical Oncology), SNMMI(Society of Nuclear Medicine and Molecular Imaging). Summaries of new, ongoing and updated research in the areas of thoracic oncology are acceptable for submission and presentation. All clinical recommendations must be based on evidence that is accepted within the profession as adequate justification for their indications and contraindications in the care of patients. font-weight: 700; 2023 ASCO Annual Meeting - American Society Of Clinical Oncology The next ASCO Annual Meeting is scheduled for June 2-6, 2023. Presentations must offer a balanced view of current medical practice that includes discussion of all available therapeutic products, including benefits and risks associated with each.